Partners: Organizations

Program for Appropriate Technology in Health (PATH)

 
rule

Accelerated Development & Introduction Program (ADIP) for Rotavirus Vaccine

To conduct surveillance of rotavirus in Asia. To assess the burden of diease, identify peculiarities in its epidemiology, create an awareness of the local importance of the disease, characterize a sample of strains in circulation, and prepare methods to monitor the impact of a vaccination program.

  • Funding Partners: Program for Appropriate Technology in Health (PATH)
  • Program Partners: National Center for Immunization and Respiratory Diseases, CDC
Related Information:

 

rule

Malaria Scholars Project

To increase CDC's capacity to provide the necessary leadership and technical assistance required to successfully address the global malaria problem by hiring and training a cadre of malaria specialists.

  • Funding Partners: BASF Corporation, Canadian Red Cross, Program for Appropriate Technology in Health (PATH), Vestergaard Frandsen SA
  • Program Partners: National Center for Zoonotic, Vector-borne and Enteric Diseases, CDC
Related Information:

 

rule

Protocol to Measure the Burden of Pneumonia in Mozambique

To conduct prospective, population-based surveillance for severe pneumonia in children 0 - 23 months of age in Manhica, Mozambique.

  • Funding Partners: Program for Appropriate Technology in Health (PATH)
  • Program Partners: National Center for Immunization and Respiratory Diseases, CDC

 

rule

Rotavirus Vaccine Development in India

To develop a partnership with a local manufacturer to produce and test an oral rotavirus vaccine in India. To assess the burden and epidemiology of rotavirus and prepare methods to monitor the impact of a vaccination program.

  • Funding Partners: Program for Appropriate Technology in Health (PATH)
  • Program Partners: Christian Medical College; India Institute of Science; Indian Council for Medical Research; National Center for Immunization and Respiratory Diseases, CDC
Related Information:

 

rule

Asian Rotavirus Surveillance Program - Phase II

To establish active sentinel hospital surveillance and disease burden studies for rotavirus gastroenteritis in Asia.

  • Funding Partners: GlaxoSmithKline Biologicals, Program for Appropriate Technology in Health (PATH)
  • Program Partners: National Center for Infectious Diseases, CDC
Related Information:

This program is no longer active.